Characteristics of Acute Respiratory Failure in Patients with Type 1 Hepatorenal Syndrome (HRS-1) Treated with Terlipressin and Albumin in an Adult General ICU in the UK

被引:0
|
作者
Cranshaw, J. H. [1 ]
Wilkins, P. L. [1 ]
机构
[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2904
引用
收藏
页数:1
相关论文
共 50 条
  • [1] REDUCTION IN ACUTE KIDNEY INJURY (AKI) STAGE IS A STRONG PREDICTOR OF SURVIVAL IN PATIENTS WITH HEPATORENAL SYNDROME TYPE-1 (HRS-1) TREATED WITH TERLIPRESSIN PLUS ALBUMIN OR ALBUMIN ALONE
    Wong, Florence
    Boyer, Thomas D.
    Sanyal, Arun J.
    Chawla, Lakhmir S.
    Pappas, Stephen Chris
    Escalante, Shannon
    Potenziano, Jim
    Jamil, Khurram
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [2] Impact of Terlipressin on Serum Sodium Levels in Patients with Hepatorenal Syndrome Type 1 (HRS-1): CONFIRM Study
    Pyrsopoulos, Nikolaos
    Khan, Mohammad
    Zafar, Zunaira
    Jamil, Khurram
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S877 - S878
  • [3] THE CONFIRM STUDY: A NORTH AMERICAN RANDOMIZED CONTROLLED TRIAL (RCT) OF TERLIPRESSIN PLUS ALBUMIN FOR THE TREATMENT OF HEPATORENAL SYNDROME TYPE 1 (HRS-1)
    Wong, Florence
    Curry, Michael P.
    Reddy, K. Rajender
    Rubin, Raymond A.
    Porayko, Michael K.
    Gonzalez, Stevan A.
    Mumtaz, Khalid
    Lim, Nicholas
    Simonetto, Douglas A.
    Sharma, Pratima
    Sanyal, Arun J.
    Mayo, Marlyn J.
    Frederick, Richard Todd
    Pappas, Stephen Chris
    Jamil, Khurram
    HEPATOLOGY, 2019, 70 (06) : 1480A - 1481A
  • [4] SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) IS A MAJOR DETERMINANT OF TREATMENT RESPONSE TO TERLIPRESSIN FOR HEPATORENAL SYNDROME TYPE 1 (HRS-1)
    Wong, F.
    Pappas, S. C.
    Boyer, T. D.
    Sanyal, A. J.
    Jamil, K.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S235 - S236
  • [5] PERCENTAGE CHANGE IN SERUM CREATININE (SCR) IS A SENSITIVE INDICATOR OF THERAPEUTIC RESPONSE TO TERLIPRESSIN IN HEPATORENAL SYNDROME TYPE 1 (HRS-1)
    Boyer, T. D.
    Sanyal, A. J.
    Pappas, S. C.
    Wong, F.
    Jamil, K.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S379 - S380
  • [6] Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure
    Wong, Florence
    Pappas, Stephen Chris
    Reddy, K. Rajender
    Vargas, Hugo
    Curry, Michael P.
    Sanyal, Arun
    Jamil, Khurram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1284 - 1293
  • [7] Terlipressin Treatment Is Associated with Significantly Increased Survival in Patients with Hepatorenal Syndrome Type 1 (HRS-1) and Low Baseline Mean Arterial Pressure (MAP), Independent of HRS Reversal
    Pappas, Stephen Chris
    Wong, Florence
    Escalante, Shannon
    Teuber, Peter
    Jamil, Khurram
    HEPATOLOGY, 2018, 68 : 560A - 560A
  • [8] Hepatorenal syndrome type 1 in patients with acute alcoholic hepatitis treated with continual terlipressin infusion in combination with albumin plasmaexpansion
    Jarcuska, P
    Hildebrand, T
    Bena, L
    Grejtovska, B
    Roland, R
    Veseliny, E
    Hancova, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 256 - 256
  • [9] Predictors of response and survival to terlipressin plus albumin or albumin alone for treatment of hepatorenal syndrome-1 (HRS-1): Combined analysis of OT-0401 and REVERSE
    Boyer, Thomas D.
    Sanyal, Arun J.
    Wong, Florence
    Pappas, Stephen Chris
    Teuber, Peter
    Escalante, Shannon M.
    Jamil, Khurram
    HEPATOLOGY, 2015, 62 : 354A - 354A
  • [10] Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
    Piano, S.
    Schmidt, H. H.
    Ariza, X.
    Amoros, A.
    Romano, A.
    Sola, E.
    Gerbes, A. L.
    Bernardi, M.
    Alessandria, C.
    Trebicka, J.
    Nevens, F.
    Gustot, T.
    Arroyo, V.
    Gines, P.
    Angeli, P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S572 - S572